CANNABIDEX

GW Research Limited

Application Filed: 2018-10-31
Trademark Application Details
Trademark Logo CANNABIDEX

Mark For: CANNABIDEX™ trademark registration is intended to cover the categories of pharmaceutical and veterinary preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for use in the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; medicinal infusions in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for use in the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; medicinal herbs, medicinal oils, pure extracts of medicinal plants and herbs for pharmaceutical use, dietetic foodstuffs specially adapted for medicinal purposes, herb teas for medicinal purposes, none of the foregoing herbs, oils, extracts, foodstuffs, or teas comprised of Cannabis sativa L or any oils, extracts, ingredients or derivatives thereof with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis. [all]

Status

2021-05-19 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88176634
Mark Literal ElementsCANNABIDEX
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2020-04-21
Basis1(b) 44(e)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentYes
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameAnessa Owen Kramer
Attorney Docket Number224143421942
Law Office AssignedL80
Employee NameLOOK, JEFFREY J

Timeline

2003-05-30Trademark Registered
2018-10-31Application Filed
2018-12-20Application Filed
2019-06-26Location: TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED
2019-12-23Status: Live/Pending
2019-12-23Transaction Date
2020-02-25Published
2020-04-21Location: INTENT TO USE SECTION
2021-04-15Status: A second request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party: GW Research Limited
AddressSovereign House, Vision Park Chivers Way, Histon Cambridge UNITED KINGDOM CB249BZ
Legal Entity TypePrivate Limited Company
Legal Entity StateUNITED KINGDOM

Documents

DrawingJPEG2018-10-31
TEAS RF New ApplicationMULTI2018-10-31
XSearch Search SummaryXML2019-06-24
Offc Action OutgoingMULTI2019-06-26
Response to Office ActionMULTI2019-12-23
Amendment and Mail Process CompleteMULTI2019-12-24
XSearch Search SummaryXML2020-01-17
TRAM Snapshot of App at Pub for OppostnMULTI2020-01-18
Notice of PublicationXML2020-02-05
Notification Of Notice of PublicationXML2020-02-05
OG Publication ConfirmationXML2020-02-25
Notice of AllowanceXML2020-04-21
Extension of Time to File SOUAPPLICATION/XML2020-09-01
ITU Extension ApprovalAPPLICATION/XML2020-09-03
ITU Unit ActionMULTI2020-09-03
Extension of Time to File SOUAPPLICATION/XML2021-04-15
ITU Extension ApprovalXML2021-04-17
ITU Unit ActionAPPLICATION/XML,IMAGE/JPEG2021-04-17

Attorney of Record

Anessa Owen Kramer
HONIGMAN LLP
39400 WOODWARD AVE STE 101
BLOOMFIELD HILLS MI 48304-5151

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical and veterinary preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for use in the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; medicinal infusions in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for use in the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; medicinal herbs, medicinal oils, pure extracts of medicinal plants and herbs for pharmaceutical use, dietetic foodstuffs specially adapted for medicinal purposes, herb teas for medicinal purposes, none of the foregoing herbs, oils, extracts, foodstuffs, or teas comprised of Cannabis sativa L or any oils, extracts, ingredients or derivatives thereof with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical and veterinary preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for use in the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; medicinal infusions in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for use in the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; medicinal herbs, medicinal oils, pure extracts of medicinal plants and herbs for pharmaceutical use, dietetic foodstuffs specially adapted for medicinal purposes, herb teas for medicinal purposes, none of the foregoing herbs, oils, extracts, foodstuffs, or teas comprised of Cannabis sativa L or any oils, extracts, ingredients or derivatives thereof with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis

Trademark Filing History

DescriptionDateProceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2021-04-17
TEAS EXTENSION RECEIVED2021-04-15
EXTENSION 2 GRANTED2021-04-1598765
EXTENSION 2 FILED2021-04-1598765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-09-03
TEAS EXTENSION RECEIVED2020-09-01
EXTENSION 1 GRANTED2020-09-0198765
EXTENSION 1 FILED2020-09-0198765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2020-04-21
PUBLISHED FOR OPPOSITION2020-02-25
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2020-02-25
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2020-02-05
ASSIGNED TO LIE2020-01-2166121
APPROVED FOR PUB - PRINCIPAL REGISTER2020-01-17
TEAS/EMAIL CORRESPONDENCE ENTERED2019-12-2388889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2019-12-23
CORRESPONDENCE RECEIVED IN LAW OFFICE2019-12-2388889
NOTIFICATION OF NON-FINAL ACTION E-MAILED2019-06-266325
NON-FINAL ACTION WRITTEN2019-06-2672008
NON-FINAL ACTION E-MAILED2019-06-266325
ASSIGNED TO EXAMINER2019-06-2472008
ASSIGNED TO EXAMINER2018-11-1978196
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-11-15
NEW APPLICATION ENTERED IN TRAM2018-11-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed